Regeneron Pharmaceuticals (REGN)
Net Income Growth
-2.91%
TTM · Period ending:
REGN Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-2.91%period ending
Latest reported-2.91%period ending
REGN TTM Net Income YoY % (-33.33% → -2.91%)
Year-over-year change
High-resolution chart · PNG
REGN net income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Net Income Growth |
|---|---|
| -146.4292% | |
| -35.092% | |
| -0.9348% | |
| 45.107% | |
| 29.8093% | |
| -56.3358% | |
| -167.4419% | |
| -942.3077% | |
| -661.2903% | |
| -44.2105% | |
| 25.8621% | |
| 87.1287% | |
| 88.6029% | |
| 68.8525% | |
| 64.1975% | |
| 37.0717% | |
| 10.231% | |
| -12.5461% | |
| -37.8723% | |
| -49.3023% | |
| -64.6739% | |
| -11.9835% | |
| 23.4528% | |
| 40.9341% | |
| 56.1905% | |
| 41.2621% | |
| 22.8643% | |
| -4.8991% | |
| -35.9223% | |
| -63.4921% | |
| -107.2917% | |
| -132.8859% | |
| -209% | |
| -281.8182% | |
| -336.3636% | |
| -365.625% | |
| -222.5806% | |
| -83.3333% | |
| -33.3333% |